RMD monthly performance report
Explore RMD's monthly returns, drawdown, and seasonality trends — updated every month.
RMD monthly report
—
Key takeaways
- ResMed (RMD) closed November 2026 at $239.53, up 4.17% for the month and −4.99% over the trailing 12 months.
- Year-to-date, RMD is −0.56%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +6.88% versus its 200-day moving average ($224.12), a bullish technical signal.
- Over the past three years, RMD has underperformed the S&P 500 by −3.78%, with a relative strength index reading of 97.8.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
ResMed ended November 2026 at $239.53, posting a monthly return of +4.17%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +4.35%.
The current quarter stands at +8.34% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +6.88% versus the 200-day moving average ($224.12).
Year-to-date, RMD is −0.56% against SPY +10.62%, a gap of −11.18%. The stock is currently −13.74% below its 52-week high, with maximum 3-year drawdown at −37.76%.
| Period | RMD | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.27% | −0.36% | +0.63% |
| 1 Week | +1.80% | +2.59% | −0.80% |
| 1 Month | +4.17% | −0.18% | +4.35% |
| 3 Months | +8.69% | −2.37% | +11.06% |
| 6 Months | +18.31% | +0.83% | +17.48% |
| YTD | −0.56% | +10.62% | −11.18% |
| 12 Months | −4.99% | +12.25% | −17.24% |
| 3 Years | +67.60% | +71.37% | −3.78% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2024 | +14.90% |
| #2 | Mar 2024 | +13.99% |
| #3 | Aug 2026 | +13.80% |
| #4 | Nov 2023 | +11.69% |
| #5 | Jul 2024 | +11.40% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −12.40% |
| #2 | May 2026 | −10.87% |
| #3 | Oct 2025 | −9.81% |
| #4 | Feb 2024 | −8.66% |
| #5 | Dec 2024 | −8.16% |
| Quarter | Return |
|---|---|
| Q3 2025 | +6.10% |
| Q4 2025 | −12.00% |
| Q1 2026 | −6.80% |
| Q2 2026 | −13.19% |
| Q3 2026 | +13.45% |
| Q4 2026 (QTD) | +8.34% |
| Year | Return |
|---|---|
| 2023 | −17.35% |
| 2024 | +32.94% |
| 2025 | +5.33% |
| 2026 | −0.56% |
| Metric | Value |
|---|---|
| 52-Week High | $277.67 (2026-02-10) |
| 52-Week Low | $180.26 (2026-06-02) |
| Current Price | $239.53 |
| 200-Day Moving Average | $224.12 |
| Price vs 200DMA | +6.88% |
| 3-Year Maximum Drawdown | −37.76% (2026-06-02) |
| Current Drawdown from 52W High | −13.74% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 97.8 |
| 3-Year Excess Return vs S&P 500 | −3.78% |
| RS Peak | 142.2 (Aug 2025) |
| RS Trough | 74.1 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was RMD's return for this report period?
RMD returned +4.17% in the latest monthly window ending 2026-11-13.
Has RMD outperformed SPY year to date?
YTD RMD: −0.56% vs SPY: +10.62%.
What is RMD's 12-month return?
−4.99% over the trailing 12 months.
Is RMD above or below its 200-day moving average?
Price is +6.88% versus 200DMA ($224.12).
What is the maximum drawdown in the 3-year window?
−37.76% on 2026-06-02.